Funding organization: National Institutes of Health (NIH)
Total funding amount: Estimated $20 million for fiscal year 2023
Duration: Applications due by September 5, 2025
Primary objective: Support research leading to innovative products/services for AD/ADRD
Key stakeholders: Small business concerns, researchers, patients with AD/ADRD
Funding source: U.S. government
Funding type: Grant (SBIR)
Significance: Addresses critical health issues related to aging and dementia
Grant frequency: Recurring
Eligible organization types: U.S. small business concerns (SBCs)
Qualifications: Must be organized for profit, with a place of business in the U.S.
Size requirements: Not more than 500 employees
Geographic location: Must operate primarily within the U.S.
Ownership: More than 50% owned by U.S. citizens or permanent residents
Previous relationship with funder: Not specified
Prevention: Behavioral, environmental, pharmacological, and nutritional interventions
Diagnosis: Development of sensitive and specific tests for mild cognitive impairment and dementia
Treatment: Discovery and evaluation of drugs and therapies for cognitive decline
Care: Technologies for in-home use and support for individuals with AD/ADRD
Technical expertise: Relevant experience in AD/ADRD research
Infrastructure: Not specified
Team composition: Must include qualified personnel with relevant expertise
Quality standards: Must adhere to NIH guidelines
Risk management: Not specified
Maximum funding amount: $2.5 million for Phase II projects
Minimum funding amount: $500,000 for Phase I projects
Eligible costs: Direct costs, indirect costs, and fees
Matching fund requirements: Not specified
Payment schedule: Not specified
Application deadlines: September 5, 2025
Earliest start date: January 5, 2023
Reporting schedule: Not specified
Monitoring and evaluation: Not specified
Compliance with NIH Grants Policy Statement required
Data protection and privacy regulations: Not specified
Environmental compliance: Not specified
Applications must be submitted electronically via Grants.gov
Required documentation: SBIR/STTR application forms
Evaluation criteria: Scientific merit and potential for commercialization
Encourages innovative approaches to AD/ADRD research
Focus on reducing disparities in care for minority populations
Previous funding opportunities have focused on similar research areas
Success rates and trends in funding not specified